Allergan (AGN) call volume and option implied volatility elevated into EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Allergen (AGN) PT Lowered to $200 at Mizuho Securities
January 30, 2019 8:21 AM ESTMizuho Securities analyst Irina Koffler lowered the price target on Allergen (NYSE: AGN) to $200.00 (from $213.00) while maintaining a Buy rating. Mizuho Securities raised our 2019 revenue from $15.0B to $15.1B due to continued Restasis durability in 1Q:19. Koffler also slightly lowered the tax rate (to... More
